BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

Main Inclusion Criteria: * Subject has provided a written informed consent * Single de novo lesion with ≥ 50% and \<100% stenosis in up to 2 coronary arteries * The target lesion length is ≤ 26 mm * The target reference vessel diameter is ≥ 2.0 mm and ≤ 4.0 mm Main Exclusion Criteria: * Evidence of myocardial infarction within 72 hours prior to index procedure * Unprotected left main coronary artery disease (stenosis \>50%) * Three-vessel coronary artery disease at time of procedure Thrombus in target vessel * Target lesion involves a side branch \> 2.0 mm in diameter * Heavily calcified lesion * Target lesion is located in or supplied by an arterial or venous bypass graft